Zhenzhen Hui

438 total citations
21 papers, 290 citations indexed

About

Zhenzhen Hui is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhenzhen Hui has authored 21 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhenzhen Hui's work include Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). Zhenzhen Hui is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). Zhenzhen Hui collaborates with scholars based in China, United States and Spain. Zhenzhen Hui's co-authors include Xiubao Ren, Xinwei Zhang, Weijiao Du, Feng Wei, Jian You, Yulong Chen, Wenwen Yu, Runmei Li, Tao Wang and Jiali Zhang and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Immunology.

In The Last Decade

Zhenzhen Hui

20 papers receiving 286 citations

Peers

Zhenzhen Hui

ONCOL

IMMUN

PRM

CCM

Wala Ben Kridis Tunisia

Tomoyuki Sasaki Japan

Ephraim Tang Canada

Antonio Zanon Italy

Mahmood Al‐Dhaheri Qatar

Yuying Li China

Zhi‐Jie Cong China

Navyatha Mohan United States

M. Pulido France

Alisia Cesta Italy

Wala Ben Kridis Tunisia

Zhenzhen Hui

126 ×0.6

ONCOL

76 ×0.7

IMMUN

61 ×0.7

PRM

20 ×0.3

CCM

34 ×0.7

Citations per year, relative to Zhenzhen Hui Zhenzhen Hui (= 1×) peers Wala Ben Kridis

Countries citing papers authored by Zhenzhen Hui

Since Specialization

Citations

This map shows the geographic impact of Zhenzhen Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenzhen Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenzhen Hui more than expected).

Fields of papers citing papers by Zhenzhen Hui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenzhen Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenzhen Hui. The network helps show where Zhenzhen Hui may publish in the future.

Co-authorship network of co-authors of Zhenzhen Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenzhen Hui. A scholar is included among the top collaborators of Zhenzhen Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenzhen Hui. Zhenzhen Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Errui, Hailiang Chu, Jing Tang, et al.. (2025). Exploring a phase-compatible surface engineering for enhancing the structural stability in Li-rich layered oxides. Journal of Material Science and Technology. 250. 165–174.

Zhang, Dong, Min Wang, Gen Liu, et al.. (2024). Novel FABP4+C1q+ macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK/JAK/STAT axis. Cell Death and Disease. 15(10). 717–717. 9 indexed citations

Zeng, Ziqing, Weijiao Du, Fan Yang, et al.. (2024). The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma. The Journal of Pathology. 262(4). 517–528. 3 indexed citations

Wang, Jian, Hao Wang, Xuena Yang, et al.. (2024). Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8+ T lymphocytes infiltration. Frontiers in Immunology. 15. 1302761–1302761. 3 indexed citations

Yu, Wenwen, Ting Liu, Gen Liu, et al.. (2024). Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors. Cancer Medicine. 13(14). e70011–e70011. 5 indexed citations

Du, Chao, Zhenzhen Hui, Na Li, et al.. (2024). Investigation of the antioxidative potential of Meretrix meretrix L. derived peptides from simulated gastrointestinal digestion: In vitro and in silico insights. LWT. 198. 115939–115939. 7 indexed citations

Luo, Jing, Zhenzhen Hui, Hua Zhao, et al.. (2023). Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4⁺ T cells through regulating type 2 conventional dendritic cells. Theranostics. 13(14). 4836–4857. 24 indexed citations

Hui, Zhenzhen, Dong Zhang, Yulong Chen, et al.. (2023). PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells. npj Precision Oncology. 7(1). 48–48. 14 indexed citations

Hui, Zhenzhen, Jiali Zhang, Xiaoling Li, et al.. (2022). Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC). Cell Death and Disease. 13(7). 607–607. 39 indexed citations

10.

Wang, Yang, et al.. (2022). Galectin-9 expression clinically associated with mature dendritic cells infiltration and T cell immune response in colorectal cancer. BMC Cancer. 22(1). 1319–1319. 9 indexed citations

11.

Chen, Yulong, Bo Yan, Feng Xu, et al.. (2021). Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer. Translational Lung Cancer Research. 10(5). 2193–2204. 23 indexed citations

12.

Hui, Zhenzhen, Jiali Zhang, Yu Zheng, et al.. (2021). Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs. Frontiers in Immunology. 12. 619932–619932. 21 indexed citations

13.

Han, Ying, Di Mu, Ting Liu, et al.. (2020). Autologous cytokine‐induced killer (CIK) cells enhance the clinical response to PD‐1 blocking antibodies in patients with advanced non‐small cell lung cancer: A preliminary study. Thoracic Cancer. 12(2). 145–152. 13 indexed citations

14.

Chen, Yulong, Lianmin Zhang, Bo Yan, et al.. (2020). Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer. Translational Lung Cancer Research. 9(3). 761–767. 10 indexed citations

15.

Hui, Zhenzhen, Jiali Zhang, Shanshan Xiao, et al.. (2020). Comprehensive immune cell analysis from lung cancer patients with PD-1 inhibitor neoadjuvant immunotherapy using single cell sequencing.. Journal of Clinical Oncology. 38(15_suppl). e21001–e21001. 1 indexed citations

16.

Dong, Xifeng, Zewei Zhou, Zhiwei Xiao, et al.. (2018). Hippocampal-Sparing Prophylactic Cranial Irradiation in Small Cell Lung Cancer: A Phase II Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 102(3). e722–e722. 3 indexed citations

17.

Li, Runmei, Yan Fang, Liang Liu, et al.. (2016). Cytokine-induced killer cell therapy for the treatment of primary hepatocellular carcinoma subsequent to liver transplantation: A case report. Oncology Letters. 11(3). 1885–1888. 5 indexed citations

18.

Hui, Zhenzhen, et al.. (2015). Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells. Frontiers in Immunology. 6. 633–633. 15 indexed citations

19.

Xiao, Zefen, Hong Zhang, Qingyang Feng, et al.. (2015). Results and prognostic factors of 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for esophageal carcinoma. Neoplasma. 62(5). 777–786. 3 indexed citations

20.

Zhang, Xinwei, et al.. (2013). Primary hepatic angiosarcoma and potential treatment options. Journal of Gastroenterology and Hepatology. 29(5). 906–911. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact